Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Webster

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
International Journal of Antimicrobial Agents|May 11, 2024
Characterising the blood-stage antimalarial activity of pyronaridine in healthy volunteers experimentally infected with Plasmodium falciparumBridget E Barber, Rebecca Webster, Adam J Potter, et al.
Sleep|March 9, 2016
Adaptation to Life in the High Andes: Nocturnal Oxyhemoglobin Saturation in Early DevelopmentCatherine Mary Hill, Ana Baya, Johanna Gavlak, et al.
Malaria Journal|February 17, 2021
Development and evaluation of a new Plasmodium falciparum 3D7 blood stage malaria cell bank for use in malaria volunteer infection studiesStephen D Woolley, Melissa Fernandez, Maria Rebelo, et al.
Scientific Reports|April 16, 2025
Transmissibility of a new Plasmodium falciparum 3D7 bank for use in malaria volunteer infection studies evaluating transmission blocking interventionsSean A Lynch, Azrin N Abd-Rahman, Jenny M Peters, et al.
The Lancet. Infectious Diseases|October 29, 2021
Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection studyJames S McCarthy, Özkan Yalkinoglu, Anand Odedra, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2023
Characterizing the Blood-Stage Antimalarial Activity of Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparumBridget E Barber, Azrin N Abd-Rahman, Rebecca Webster, et al.
BMC Medicine|November 28, 2024
Characterizing the pharmacological interaction of the antimalarial combination artefenomel-piperaquine in healthy volunteers with induced blood-stage Plasmodium falciparum to predict efficacy in patients with malariaAzrin N Abd-Rahman, Daniel Kaschek, Anne Kümmel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2022
Transmission Blocking Activity of Low-dose Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparumRebecca Webster, Hayley Mitchell, Jenny M Peters, et al.
Plos One|May 9, 2024
Clinical effectiveness of drop-in mental health services at paediatric hospitals: A non-randomised multi-site study for children and young people and their families - study protocolAnna Roach, Sophie Bennett, Isobel Heyman, et al.
BMC Health Services Research|April 14, 2025
Clinical effectiveness of drop-in mental health services in paediatric healthcare settings: a non-randomised multi-site study for children, young people and their familiesAnna Roach, Sophie Bennett, Isobel Heyman, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
International Journal of Antimicrobial Agents|May 11, 2024
Characterising the blood-stage antimalarial activity of pyronaridine in healthy volunteers experimentally infected with Plasmodium falciparumBridget E Barber, Rebecca Webster, Adam J Potter, et al.
Sleep|March 9, 2016
Adaptation to Life in the High Andes: Nocturnal Oxyhemoglobin Saturation in Early DevelopmentCatherine Mary Hill, Ana Baya, Johanna Gavlak, et al.
Malaria Journal|February 17, 2021
Development and evaluation of a new Plasmodium falciparum 3D7 blood stage malaria cell bank for use in malaria volunteer infection studiesStephen D Woolley, Melissa Fernandez, Maria Rebelo, et al.
Scientific Reports|April 16, 2025
Transmissibility of a new Plasmodium falciparum 3D7 bank for use in malaria volunteer infection studies evaluating transmission blocking interventionsSean A Lynch, Azrin N Abd-Rahman, Jenny M Peters, et al.
The Lancet. Infectious Diseases|October 29, 2021
Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection studyJames S McCarthy, Özkan Yalkinoglu, Anand Odedra, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2023
Characterizing the Blood-Stage Antimalarial Activity of Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparumBridget E Barber, Azrin N Abd-Rahman, Rebecca Webster, et al.
BMC Medicine|November 28, 2024
Characterizing the pharmacological interaction of the antimalarial combination artefenomel-piperaquine in healthy volunteers with induced blood-stage Plasmodium falciparum to predict efficacy in patients with malariaAzrin N Abd-Rahman, Daniel Kaschek, Anne Kümmel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2022
Transmission Blocking Activity of Low-dose Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparumRebecca Webster, Hayley Mitchell, Jenny M Peters, et al.
Plos One|May 9, 2024
Clinical effectiveness of drop-in mental health services at paediatric hospitals: A non-randomised multi-site study for children and young people and their families - study protocolAnna Roach, Sophie Bennett, Isobel Heyman, et al.
BMC Health Services Research|April 14, 2025
Clinical effectiveness of drop-in mental health services in paediatric healthcare settings: a non-randomised multi-site study for children, young people and their familiesAnna Roach, Sophie Bennett, Isobel Heyman, et al.
Pageof 4